Mereo BioPharma Group Plc (MREO)
0.3332
0.00 (0.00%)
USD |
NASDAQ |
May 27, 15:53
Mereo BioPharma Group Cash from Investing (Quarterly) : -0.2995M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -0.1037M |
| Autolus Therapeutics Plc | 95.99M |
| Bicycle Therapeutics Plc | -0.7118M |
| DBV Technologies SA | -0.3011M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.305M |
| Free Cash Flow | -27.29M |
| Free Cash Flow Per Share (Quarterly) | -0.0287 |
| Free Cash Flow to Equity (Quarterly) | -4.402M |
| Free Cash Flow to Firm (Quarterly) | -4.604M |
| Free Cash Flow Yield | -51.23% |